When we analyzed the sensitivity of all biomarkers according to the classification as a primary (NS1/IgM/IgG-) or a secondary infection (NS1/IgM/IgG+), the Humasis RDT kit had similar sensitivities for primary (63.64%) and secondary infections (65.52%). This evidence concerns the gene CD40LG and infection.